Source: Hirz, T., et al. Neutrophil Isolation and Analysis to Determine their Role in Lymphoma Cell Sensitivity to Therapeutic Agents. J. Vis. Exp. (2016).
This video demonstrates an assay investigating the role of neutrophil-like cells in safeguarding lymphoma cells against the cytotoxicity of chemotherapeutic agents. A 3D co-culture, consisting of lymphoma and neutrophil-like cells, is established and exposed to vincristine—a chemotherapy drug. Direct contact with the neutrophil-like cells induces an upregulation of anti-apoptotic proteins in the lymphoma cells, thereby promoting their survival in the presence of vincristine.
1. Differentiation of HL60 Cells along the Granulocytic Pathway and Their Coculture with RL Lymphoma B Cells in 3D Model
Figure 1. Structural Parameters of Differentiated HL60 Cells. (A) Forward-scatter (FSC) and side-scatter (SSC) plots represent HL60 and differentiated HL60 cells (HL60diff). (B) HL60 and HL60diff cells were labeled with anti-CD11b-AF700 or anti-CD38-APC followed by flow cytometry analysis. After gating on each cell population in the FSC-A vs. SSC-A scatter plot (A), the cells were analyzed for the expressions of CD11b or CD38. (C) HL60 cells show morphological changes consistent with differentiation toward granulocytes. Photos were taken by microscope with 100X magnification. Bold black arrow point the multi-lobed nucleus. Graphs are representative of five independent experiments.
Figure 2. Neutrophil-like HL60diff Cells Protect RL Lymphoma Cells against Vincristine in 3D Culture. RL cells were cultured alone or together with HL60diff cells at RL:HL60diff ratio 1:10 for 7 days in basement membrane matrix. On day 5, vincristine (VCR) was added at a concentration of 10 nM. Spheroids were dissociated on day 7 and cells were labeled with anti-CD19-PECy7 and anti-CD38-APC then resuspended with annexin V-FITC and PI followed by flow cytometric analysis. (A) Forward-scatter (FSC) and side-scatter (SSC) plot represents the gates of RL cells and HL60diff cells. (B) Bi-dimensional dot-blot shows the percentages of alive and apoptotic RL cells cultured alone and treated with 10 nM vincristine. (C) Bi-dimensional dot-blot shows the percentages of alive and apoptotic RL cells co-cultured with HL60diff and treated with 10 nM vincristine. (D) The bar graph represents the percentage of alive RL cells. Data are expressed as mean ± SD. ***p ≤0.001.
The authors have nothing to disclose.
RPMI 1640 | Gibco Invitrogen | 21875-034 | |
Fetal bovine serum (FBS) | Gibco Invitrogen | 10270-106 | |
Phosphate-buffered saline (PBS contains calcium and magnesium) | Gibco Invitrogen | 14040-091 | |
Vincristine | EG labo | ||
BD Matrigel basement membrane matrix | BD Biosciences | 354234 | Put at 4 oC overnight before the day of the experiment |
Dimethyl sulfoxide (DMSO) | Sigma-Aldrich | D8418 | |
Retinoic acid | Sigma-Aldrich | R2625 | |
Bovine serum albumin (BSA) | Sigma-Aldrich | A7906 | |
Ethylenediaminetetraacetic acid (EDTA) | Sigma-Aldrich | E5134 | |
Annexing V-FLOUS staining kit | Roche | 11 988 549 001 | |
Kit RAL 555 Modified Giemsa staining kit | Cosmos Biomedical | CB361550-0000 | |
LSRII flow cytometry | BD Biosciences | ||
Cytocentrifuge | Thermo Scientific | ||
Leica DMR-XA microscope | Leica Microsystems | ||
Cellometer Auto T4 Cell Viability Counter | Nexcelom Bioscience |